What are the optimal pharmacokinetic properties of antipsychotic medications?

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 1, 2012, Pages 117-121

  Kang, Ung Gu ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Antipsychotics; Dopamine; Koff; Sensitization; Simulation

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; RISPERIDONE;

ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ACTIVITY; DISSOCIATION CONSTANT; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; HUMAN; LOW DRUG DOSE; PHARMACOLOGICAL PARAMETERS; PSYCHOSIS; RECEPTOR BINDING; SENSITIZATION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; PROTEIN BINDING; RECEPTORS, DOPAMINE D2;

EID: 82555172179     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.08.009     Document Type: Article

References (26)

1. Agnati L.F., Guidolin D., Guescini M., Genedani S., Fuxe K. Understanding wiring and volume transmission. Brain Res Rev 2010, 64:137-159.
2. Dreyer J.K., Herrik K.F., Berg R.W., Hounsgaard J.D. Influence of phasic and tonic dopamine release on receptor activation. J Neurosci 2010, 30:14273-14283.
3. Fumagalli F., Di Pasquale L., Caffino L., Racagni G., Riva M.A. Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. Eur J Neurosci 2007, 26:2756-2763.
4. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr Bull 2009, 35:549-562.
5. Kapur S., Zipursky R.B., Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 1999, 156:286-293.
6. Kapur S., Seeman P. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J Psychiatry Neurosci 2000, 25:161-166.
7. Kapur S., Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry 2001, 158:360-369.
8. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T. Evidence for striatal dopamine release during a video game. Nature 1998, 393:266-268.
9. Lieberman J.A., Sheitman B.B., Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997, 17:205-229.
10. Miller R. Schizophrenic psychology, associative learning and the role of forebrain dopamine. Med Hypotheses 1976, 2:203-211.
11. Panksepp J. Affective Neuroscience 1998, 144-163. Oxford Univ Press, Oxford.
12. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 1997, 25:192-216.
13. Pierce R.C., Kalivas P.W. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci 1997, 17:3254-3261.
14. Pilotte N.S., Sharpe L.G., Kuhar M.J. Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J Pharmacol Exp Ther 1994, 269:963-969.
15. Post R.M., Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature 1976, 260:731-732.
16. Reimer A.R., Martin-Iverson M.T. Nimodipine and haloperidol attenuate behavioural sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion induced by cocaine. Psychopharmacology (Berl) 1994, 113:404-410.
17. Rice M.E., Cragg S.J. Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway. Brain Res Rev 2008, 58:303-313.
18. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
19. Salimpoor V.N., Benovoy M., Larcher K., Dagher A., Zatorre R.J. Anatomically distinct dopamine release during anticipation and experience of peak emotion to music. Nat Neurosci 2010, 14:257-262.
20. Seeman P. All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2 receptors. CNS Neurosci Ther 2011, 17:118-132.
21. Seeman P., Lee T., Chau-Wong M., Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976, 261:717-719.
22. Seeman P., Weinshenker D., Quirion R., Srivastava L.K., Bhardwaj S.K., Grandy D.K. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci USA 2005, 102:3513-3518.
23. Shuto T., Seeman P., Kuroiwa M., Nishi A. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats. Eur J Neurosci 2008, 27:2551-2557.
24. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 1991, 548:100-110.
25. Ujike H., Sato M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann N Y Acad Sci 2004, 1025:279-287.
26. Vezina P. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci 1996, 16:2411-2420.